What is Inotiv Inc (NOTV)?

Inotiv Inc (NOTV) Stock Analysis

$0.080

-0.013 (-15.89%)At close

Loading chart…

High: 0.098
Open: 0.085
VWAP: 0.09
Vol: 17.27M
Mkt Cap: 44.93M
Low: 0.080
Amount: 1.48M
EV/EBITDA, TTM: -14.11

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Valuation Metrics

The current forward P/E ratio for Inotiv Inc (NOTV) is 3.72, compared to its 5-year average forward P/E of -0.40.

Forward P/E

Fair

5Y Average P/E

-0.40

Current P/E

3.72

Overvalued

13.84

Undervalued

-14.64

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

11.00

Current EV/EBITDA

-14.11

Overvalued

20.59

Undervalued

1.41

Forward P/S

Fair

5Y Average P/S

0.42

Current P/S

0.00

Overvalued

0.95

Undervalued

-0.10

Alphio AI Price Scenarios for NOTV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bull

Bull · 25%NOTV

$2.18

Scenario price

Base

Base · 50%NOTV

$2.07

Scenario price

Bear

Bear · 25%NOTV

$1.58

Scenario price

Events Timeline

2026-07-14 (ET)